Protagonist Therapeutics, Inc. (PTGX)

91.20 -3.04 (-3.23%) USD  |  NASDAQ  |  Mar 03, 16:00
91.20 0.00 (0.00%) After-Hours: 17:30
More

Protagonist Therapeutics Stock Based Compensation (5 Year Growth)

Stock Based Compensation (5 Year Growth) Chart

View Stock Based Compensation (5 Year Growth) for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (5 Year Growth) Range, Past 5 Years

View Stock Based Compensation (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (5 Year Growth) Benchmarks

View Stock Based Compensation (5 Year Growth) Benchmarks
Start Trial
Johnson & Johnson Upgrade
ADMA Biologics, Inc. Upgrade
Glaukos Corp. Upgrade
Krystal Biotech, Inc. Upgrade
Olema Pharmaceuticals, Inc. --